A Significant Step Forward: NINA Medical Secures a NIS 5M Grant from the Israel Innovation Authority

We are thrilled to announce a major milestone for NINA Medical: securing a prestigious NIS 5 million grant from the Israel Innovation Authority (IIA).

This marks the fourth time the Innovation Authority has demonstrated its confidence in our vision, proprietary technology, and the team driving our development. In a dynamic and competitive industry like MedTech, such recurring recognition is far from taken for granted—it fills us with pride and reinforces our deep commitment to continue breaking new ground.

Turning Technological Vision into Clinical Reality

Our long-standing partnership and continuous support from the Israel Innovation Authority serve as a catalyst, enabling us to accelerate our R&D, clinical evaluation, and regulatory milestones. Our objective is well-defined: to deliver a safe, effective, and completely non-invasive treatment for Benign Prostatic Hyperplasia (BPH)—a widespread condition that significantly impacts the daily quality of life for millions of men worldwide.

We believe that pioneering an advanced therapeutic approach—one that combines clinical precision with an optimal patient experience while eliminating the need for invasive procedures—will redefine the standard of care in modern urology.

A Heartfelt Thank You to the Israeli Ecosystem

We extend our sincere gratitude to the Israel Innovation Authority team for their professionalism, ongoing guidance, and forward-looking strategic vision. Growing within the Israeli ecosystem—a vibrant environment that consistently leads, inspires, and delivers life-changing innovations to the global healthcare and scientific landscape—is both an honor and a profound mission.

Empowered by this momentum, we forge ahead with full energy toward the next stages of our development and clinical journey.

‍